Specifically, patients in stage 1 (low expression, n ═ 201; high expression, n ═ 64) ccRCC with low mortality did not exhibit any significant influence of Sirt1 expression on their survival outcomes. The gene discussed is SIRT1; the disease is nonpapillary renal cell carcinoma.